Otezla timeline helpful, thanks. I tried to find that, couldn't.
Throughout 2017 the company publicly stated P interim results release as a milestone, so if it did receive them without releasing them then it would be problematic if the results were poor and they had subsequently issued shares. I do not believe that to be the case. It is just puzzling and disappointing, as I said before in Q4. Biotech... Looking forward to the final results.